Nafarelin acetate
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 341 publications
A study on the efficacy and safety of long-term adjusted low-dose gonadotropin-releasing hormone agonist therapy for uterine fibroids and adenomyosis.
Journal: The journal of obstetrics and gynaecology research
Published: March 09, 2024
Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors.
Journal: International journal of molecular sciences
Published: February 27, 2023
Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not?
Journal: Human reproduction open
Published: November 12, 2022
Caspase-3 gene expression in human luteinized granulosa cells is inversely correlated with the number of oocytes retrieved after controlled ovarian stimulation.
Journal: Human fertility (Cambridge, England)
Published: July 26, 2017
Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system.
Journal: Pharmaceutical development and technology
Published: April 22, 2017
Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.
Journal: Fertility and sterility
Published: February 24, 2016
p27 and its ubiquitin ligase Skp2 expression in endometrium of IVF patients with repeated hormonal stimulation.
Journal: Reproductive biomedicine online
Published: May 21, 2015
GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates.
Journal: The Australian & New Zealand journal of obstetrics & gynaecology
Published: June 27, 2014
Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial.
Journal: Fertility and sterility
Published: June 20, 2013
Spontaneous reports of seizure in association with leuprolide (lupron depot), goserelin (zoladex implant), and naferelin (synarel nasal spray).
Journal: Obstetrics and gynecology
Published: May 03, 2013
Last Updated: 02/24/2026